{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:42:41Z","timestamp":1779320561489,"version":"3.51.4"},"reference-count":13,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Einstein (S\u00e3o Paulo)"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:p>ABSTRACT Objective: To assess adherence of the prescribing physicians in a private cancer care center to the American Society of Clinical Oncology guideline for antiemetic prophylaxis, in the first cycle of antineoplastic chemotherapy. Methods: A total of 139 chemotherapy regimens, of 105 patients, were evaluated retrospectively from 2011 to 2013. Results: We observed 78% of non-adherence to the guideline rate. The main disagreements with the directive were the prescription of higher doses of dexamethasone and excessive use of 5-HT3 antagonist for low risk emetogenic chemotherapy regimens. On univariate analysis, hematological malignancies (p=0.005), the use of two or more chemotherapy (p=0.05) and high emetogenic risk regimes (p=0.012) were factors statistically associated with greater adherence to guidelines. Treatment based on paclitaxel was the only significant risk factor for non-adherence (p=0.02). By multivariate analysis, the chemotherapy of high emetogenic risk most correlated with adherence to guideline (p=0.05). Conclusion: We concluded that the adherence to guidelines is greater if the chemotherapy regime has high emetogenic risk. Educational efforts should focus more intensely on the management of chemotherapy regimens with low and moderate emetogenic potential. Perhaps the development of a computer generated reminder may improve the adherence to guidelines.<\/jats:p>","DOI":"10.1590\/s1679-45082015ao3097","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T22:09:52Z","timestamp":1436047792000},"page":"221-225","source":"Crossref","is-referenced-by-count":11,"title":["Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy"],"prefix":"10.1590","volume":"13","author":[{"given":"Monique Sedlmaier","family":"Fran\u00e7a","sequence":"first","affiliation":[{"name":"Hospital Israelita Albert Einstein, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Luiz Serrano","family":"Us\u00f3n Junior","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri Philippe Pimentel Vieira","family":"Antunes","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard Lobato","family":"Prado","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos del Cistia","family":"Donnarumma","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taciana Sousa","family":"Mut\u00e3o","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heloisa Veasey","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auro del","family":"Giglio","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina do ABC, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra0706547","article-title":"Chemotherapy-induced nausea and vomiting","volume":"358","author":"Hesketh PJ","year":"2008","journal-title":"N Engl J Med"},{"issue":"31","key":"ref2","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update","volume":"29","author":"Basch E","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1997.15.1.103","article-title":"Proposal for classifying the acute emetogenicity of cancer chemotherapy","volume":"15","author":"Hesketh PJ","year":"1997","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/s00520-010-1003-x","article-title":"Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity\u2013state of the art","volume":"19","author":"Grunberg SM","year":"2011","journal-title":"Support Care Cancer"},{"issue":"34","key":"ref5","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1200\/JCO.2013.53.3943","article-title":"American Society of Clinical Oncology 2013 top five list in oncology","volume":"31","author":"Schnipper LE","year":"2013","journal-title":"J Clinl Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"v232","DOI":"10.1093\/annonc\/mdq194","article-title":"Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference","volume":"21","author":"Roila F","year":"2010","journal-title":"Ann Oncol"},{"issue":"3","key":"ref7","first-page":"5","article-title":"Uso de antiem\u00e9ticos","author":"Stefani SD","year":"2011","journal-title":"Rev Bras Cuidados Paliativos"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/annonc\/mds021","article-title":"The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)","volume":"23","author":"Aapro M","year":"2012","journal-title":"Ann Oncol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00520-010-1079-3","article-title":"Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting","volume":"20","author":"Burmeister H","year":"2012","journal-title":"Support Care Cancer"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/cncr.27899","article-title":"Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer","volume":"119","author":"Gomez DR","year":"2013","journal-title":"Cancer"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.18553\/jmcp.2012.18.5.385","article-title":"Assessment of the relationship between adherence with antiemetic drug therapy and control of nausea and vomiting in breast cancer patients receiving anthracycline-based chemotherapy","volume":"18","author":"Chan A","year":"2012","journal-title":"J Manag Care Pharm"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00520-013-1801-z","article-title":"Antiemetic prophylaxis and frequency of chemotherapy-induced nausea and vomiting in palliative first-line treatment of colorectal cancer patients: the Northern Bavarian IVOPAK I Project","volume":"21","author":"Koch S","year":"2013","journal-title":"Support Care Cancer"},{"key":"ref13","series-title":"Barriers to guidelines adherence. Improving physician adherence to clinical practice guidelines: barriers and strategies for change","author":"Kenefick H","year":"2008"}],"container-title":["Einstein (S\u00e3o Paulo)"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/eins\/v13n2\/1679-4508-eins-13-2-0221.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T16:26:10Z","timestamp":1599236770000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1679-45082015000200009&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1679-45082015000200009"],"URL":"https:\/\/doi.org\/10.1590\/s1679-45082015ao3097","relation":{},"ISSN":["1679-4508"],"issn-type":[{"value":"1679-4508","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}